Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Receivables (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Receivables for 9 consecutive years, with $949.5 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables rose 4.55% year-over-year to $949.5 million; the TTM value through Mar 2026 reached $949.5 million, up 4.55%, while the annual FY2025 figure was $864.2 million, 5.21% up from the prior year.
  • Receivables hit $949.5 million in Q1 2026 for Select Medical Holdings, up from $864.2 million in the prior quarter.
  • Across five years, Receivables topped out at $1.1 billion in Q1 2024 and bottomed at $724.1 million in Q4 2023.
  • Average Receivables over 5 years is $936.0 million, with a median of $941.4 million recorded in 2022.
  • Year-over-year, Receivables dropped 24.38% in 2023 and then grew 13.79% in 2024.
  • Select Medical Holdings' Receivables stood at $957.6 million in 2022, then decreased by 24.38% to $724.1 million in 2023, then rose by 13.43% to $821.4 million in 2024, then grew by 5.21% to $864.2 million in 2025, then increased by 9.87% to $949.5 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $949.5 million, $864.2 million, and $825.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.